|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.60 GBX | +4.21% |
|
+3.80% | +11.71% |
| 07-01 | Novacyt S.A. - Shareholder/Analyst Call | |
| 06-01 | Novacyt plans job cuts; EnSilica's contract win | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Medical Devices
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 621M | - | - | - | ||
| 526M | - | - | - | - | - |
| 106M | - | - | - | - | - |
| 99.35M | - | - | - | - | - |
- Stock Market
- Stocks
- ALNOV Stock
- NCYT Stock
- Charts Novacyt
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
